• Toxicological Research
• /
• v.29 no.2
• /
• pp.137-142
• /
• 2013

Arsenic (As) is a well-known human carcinogen and its dietary exposure has been found to be the major route of entry into general population. This study was performed to assess the body levels of As and their associated factors in Korean adults by analyzing total As in urine. Urine and blood samples were collected from 580 adults aged 20 years and older, who had not been exposed to As occupationally. Demographic information was collected with the help of a standard questionnaire, including age, smoking, alcohol intake, job profiles, and diet consumed in the last 24 hrs of the study. Total As, sum of As(III), As(V), monomethylarsonic acid (MMA), dimethylarsinic acid (DMA), in urine was determined using atomic absorption spectrometer involving hydride generation method. The geometric mean concentration of total As in urine was $7.10{\mu}g/L$. Urine As was significantly higher in men ($7.63{\mu}g/L$) than in women ($6.75{\mu}g/L$). Age, smoking, alcohol consumption, and job profiles of study subjects did not significantly affect the concentration of As in urine. No significant relationship was observed between body mass index (BMI), Fe, and total cholesterol in serum and urinary As. Urine As level was positively correlated with seaweeds, fishes & shellfishes, and grain intake. A negative correlation between urinary As level and HDL-cholesterol in serum and meat intake was observed. Overall, these results suggest that urinary As concentration could be affected by seafood consumption. Therefore, people who frequently consume seafood and grain need to be monitored for chronic dietary As exposure.

• Journal of Korean Society of Occupational and Environmental Hygiene
• /
• v.18 no.2
• /
• pp.108-114
• /
• 2008

Objectives : To estimate the normal range of blood and urine cadmium levels using data from occupationally non-exposed office workers to cadmium in selected Korean women. Methods : A total of 437 women from healthy office workers were analyzed. To analyze blood and urine cadmium levels, blood and urine samples of study subjects were collected carefully and analyzed. Using a structured questionnaire, characteristics of the study subjects were investigated by well trained interviewers. Results : Mean blood cadmium concentration (CdB) was $0.46\;{\mu}g/{\ell}$ (GM; 0.16), whereas mean urine cadmium concentration (CdU) was $0.94\;{\mu}g/g$ creatinine (GM; 0.37). A significant increase of cadmium levels in blood and urine was observed by the rise of age (p=0.007; p=0.002, respectively). In the analysis of smoking state, blood and urine cadmium levels were higher in current smokers than in nonsmokers. In the multiple regression analysis, the rise of age and currently smoking were observed as a significant factor associated with cadmium level. Conclusion : These findings suggest that mean cadmium level in blood and urine indicated a relatively low level, although the rise of age and currently smoking were observed as a significant factor related to cadmium level. It can be used for the basic data to prevent harmful effects of cadmium exposure among female workers occupationally exposed to cadmium.

• Journal of Preventive Medicine and Public Health
• /
• v.15 no.1
• /
• pp.131-137
• /
• 1982

For the purpose of the curative effects of oral D-penicillamine in lead poisoning, D-penicillamine was orally administered to 7 lead poisoned workers which were employed in glaze product industry dealing with the lead oxide ($Pb_3O_4$). The doses of D-penicillamine was 1,200mg per day which was administered by oral 7days schedules, taking for 5 days and stopping for the following 2days, repeatedly during 3 months period. (All the poisoned workers started working again in that industry after 1 month treatment, and were treated by oral D-penicillamine for 2 months still being exposed to contaminated environment.) In order to evaluate the curative effects of D-penicillamine, 10gm of whole blood and 24 hours urine were collected every 14 days during the curative period for laboratory analysis(hemoglobin, blood lead, urine $\sigma$-aminolevulinic acid, urine coproporphyrin, and urine lead levels) with the observation of the clinical symptoms. The results were as follows; 1. Oral D-penicillamine effected good curative results as that hemoglobin, blood lead, urine $\sigma$-aminolevulinic acid, and urine coproporphyrin levels were decreased below the critical level within 1 month treatment. 2. After re-exposure, oral D-penicillamine effected to some extent as that urine lead level was decreased below the critical level after 3 months treatment with disappearence of the clinical symptoms after 2 months treatment. However, the curative effects of oral D-penicillamine in the lead exposure state is questionable since increasement of blood lead level and remarkable decreasement of urine lead level after 3 months treatment can be observed.

• Journal of Environmental Health Sciences
• /
• v.27 no.3
• /
• pp.1-10
• /
• 2001

This study was performed to evaluate chromium in air and chromium concentrations in whole blood and urine of workers at chrome plating factories, and to determine the correlation between environmental and biological chromium levels. This study involved 29 workers as study group and 24 undergraduate students as control group. The geometric means(GM) of airborne hexavalent chromium and total chromium concentrations in the plating factories were 3.4 $\mu\textrm{g}$/㎥ and 10.8 $\mu\textrm{g}$/㎥, respectively. Hexavalent chromium levels in two of total 29 measurements exceeded the korean occupational exposure limit and the American Conference of Governmental Industrial Hygienists Threshold Limit Value(ACGIH-TLV) of 50$\mu\textrm{g}$/㎥. Only one sample for total chromium exceeded the Korea occupational exposure limits, the ACGIH-TLV, and the National Institute for Occupational Safety and Health Recommended Exposure Limits(NIOSH-REL) of 500 $\mu\textrm{g}$/㎥. The GM of chromium concentrations in blood and urine of workers exposed to chromium were 8.4 $\mu\textrm{g}$/L and 11.9 $\mu\textrm{g}$/L. The GM of chromium concentrations in blood and urine of workers exposed to chromium were 8.4 $\mu\textrm{g}$/L and 11.9 $\mu\textrm{g}$/L, respectively, whereas the chromium concentrations in blood and urine of the controls were 1.6 $\mu\textrm{g}$/L and 3.8 $\mu\textrm{g}$/L, respectively. There were statistically significant differences of blood and urine concentrations between study group and control group (p<0.01). The chromium concentrations in urine were most highly related to hexavalent chromium, concentration in air(r=0.642, p<0.01). Also, there was a relatively high correlation between the hexavalent chromium concentrations in air and chromium concentrations in whole blood(r=0.557, p<0.05). These results indicate that whole-blood chromium with urinary chromium could be an indicator of chromium body burden caused by exposure to chromic acid mist in plating operation.

• Biomedical Science Letters
• /
• v.2 no.2
• /
• pp.199-209
• /
• 1996

A new test strip to detect leukocytes using the myeloperoxidase in urine was developed. The reagent strip contains tetramethylbenzine, glucose and glucose oxidase. The detection limit was between 10 cells per 1$\mu$l urine(5 cells/hpf), showing greenish yellow color in the range of 10-25 cells/$\mu$l, green color in the range of 75-250 cells/$\mu$l, greenish blue color in the range of 500 cells/$\mu$l. The result can be obtained within two minute. The performance of the new method was evaluated by comparing the results of microscopic examination and other commercial products. Good correlations were shown between the values obtained by our urine strip and those by other commercial products with 172 urine samples. The results were proven that new methods were useful as primary screening reagents to detect leukocytes in urine.

• The Journal of Korean Medicine
• /
• v.22 no.2
• /
• pp.94-101
• /
• 2001

Background and Purpose : Relationship between 17-KS.17-OHCS in 24hrs urine and Deficiency Syndrome of the Kidneys had been examined, but the study about 17-KS.17-OHCS in stroke patients was rare6'. In this study, we aimed to investigate the usefulness of 24hrs urine 17-KS.17-OHCS in stroke patients as an index for the Differentiation of Deficiency Syndrome of the Kidneys. Subjects : 66 stroke patients(male : female =2 9 : 37) were selected, they were admitted in the hospital of oriental medicine, Kyunghee university(from November 1 st, 1998 to May 30th, 2000). Their age was over 65 years. The patients who had renal malfunction, hyperthyroidism, hypothyroidism were excluded and who took chlorpromazine, spironolactone, digoxin, reserpine, hormonal agent were also excluded. Methods : After we selected the patients, we investigated the Differentiation of Syndrome by use of Diagnostic Paper and examined the level of 17-KS.17-OHCS in 24hrs urine. We compared Deficiency Syndrome with non-Deficiency Syndrome of the Kidneys using of 17-KS.17-OHCS in 24hrs urine. Results : 1. Stroke did not affect 17-KS.17-OHCS excretion in 24hrs urine. 2. In 24hrs urine, 17-KS of male stroke patients and 17-OHCS of female stroke patients were lower in patients diagnosed as a Deficiency Syndrome than non-Deficiency Syndrome of the Kidneys(p<0.05). 3. Among Deficiency Syndrome of Yin, Yang, Yang and Yin of the Kidneys group, there was no differentiation of 17-KS.17-OHCS in 24hrs urine(p>0.05).

• Journal of Preventive Medicine and Public Health
• /
• v.43 no.4
• /
• pp.301-308
• /
• 2010

Objectives: In most DEHP exposure assessment studies, single spot urine sample was used. It could not compare the exposure level among studies. Therefore, we are going to represent the necessity of selection of proper sampling time of spot urine for assessing the environmental DEHP exposure, and the association urinary DEHP metabolites with steroid hormones. Methods: We collected urine and plasma from 25 men. The urine sampling times were at the end of the shift (post-shift) and the next morning before the beginning of the shift (pre-shift). Three metabolites of DEHP {mono(2-ethylhexyl) phthalate [MEHP], mono-(2-ethyl-5-hydroxyhexyl)phthalate [MEHHP], and mono(2-ethyl-5-oxohexyl)phthalate [MEOHP]} in urine were analyzed by HPLC/MS/MS. Plasma luteinzing hormone, follicle stimulating hormone, testosterone, and $17{\beta}$- estradiol were measured at pre-shift using a ELISA kit. A log-transformed creatinine-adjusted urinary MEHP, MEHHP, and MEOHP concentration were compared between the post- and pre-shift. The Pearson’s correlation was calculated to assess the relationships between log-transformed urinary MEHP concentrations in pre-shift urine and hormone levels. Results: The three urinary metabolite concentrations at post-shift were significantly higher than the concentrations in the pre-shift (p<0.0001). The plasma hormones were not significantly correlated with log-transformed creatinine - adjusted DEHP metabolites. Conclusions: To assess the environmental DEHP exposure, it is necessary to select the urine sampling time according to the study object. There were no correlation between the concentration of urinary DEHP metabolites and serum hormone levels.

• Journal of Korean Society of Occupational and Environmental Hygiene
• /
• v.1 no.2
• /
• pp.136-143
• /
• 1991

Inorganic mercury in urine and airborne was determined by cold vapor atomic absorption spectrophotometry. Detailed sampling methods and analylical results are as follows : 1. 100~200ml of urine for each person was taken in 250 ml borosilicate bottle and $K_2S_2O_8$ (0.1g/100ml urine) was added to prevent bacterial contamination. About 1001 air of workingplace was absorbed in l0ml of absorbing solution. Urine samples and absorbing solution tubes were stored at $4^{\circ}C$. Dillution solution to prepare standard solution used deionized water (D.W) for urine and absorbing solution (A.S) for air. 2. 1n this procedure deteclion limit was 1ng/ml and mercury contents of blank reagent solution was 1~2ng/ml. 3. Calibration range was $0.02{\sim}0.1{\mu}g/ml$ and in this range r.s.d for each calibration curve in D.W and A.S and ${\pm}7.9%$ and ${\pm}3.7%$, respectively. 4. Repeatability (n=5 times, conc. $0.05{\mu}g/ml$) was ${\pm}5.8%$, in D.W. and ${\pm}4.4%$ in A.S, respectively. 5. Recovery for urine adding spiked concentration ($0.05{\mu}g/ml$) was about 90%. 6. Analytical result of samples was $1{\sim}139{\mu}g/l$ in urine and ${\sim}0.127mg/m^3$ in airborne.

• Journal of Korean Society of Occupational and Environmental Hygiene
• /
• v.7 no.1
• /
• pp.49-59
• /
• 1997

This study was performed to analyze the purity of technical grade ${\alpha}$-naphthylamine, to establish optimal analytical condition of ${\alpha}$-naphthylamine in urine and to determine the urine sample of workers exposed to ${\alpha}$-naphthylamine. The purity of technical grade ${\alpha}$-naphthylamine were $96.5{\pm}2.38%$, $94.1{\pm}0.97%$, $97.0{\pm}0.02%$ by gas chromatography-mass selective detector. To analyze ${\alpha}$-naphthylamine in urine, high performance liquid chromatography-electrochemical detector and gas chromatography-electron capture detector operating conditions have been optimized by preliminary expriment. In high performance liquid chromatography-electrochemical detector, the mobile phase was consisted of acetonitrile(35%) and water(65%), and the flow rate was maintained at 1.0ml per minute. Optimal detective condition was 9.0V(10nA/V) of electrochemical detector. The recovery of sep-pak treatment method was highly estimated as pretreatment of ${\alpha}$-naphthylamine in urine. The free amine was isolated by gas chromatography-electron capture detector after basic hydrosis, sep-pak treatment, toluene elution and HFBA(heptafluoro-butyric anhydride) derivatization of urine. The recovery of ${\alpha}$-naphthylamine in urine was $98.73{\pm}3.29%$ by gas chromatography-electron capture detector. The sensitivity was more higher than that of high performance liquid chromatography-electrochemical detector. Urinary ${\alpha}$-naphthylamine was detected in only one worker among nine workers. The level of ${\alpha}$-naphthylamine in urine was 6.42 ng/ml.

• Toxicological Research
• /
• v.27 no.1
• /
• pp.15-18
• /
• 2011

The toxicities of phenanthrene (PH) and pyrene (PY) are less than benzo(a)pyrene (BaP), but both compounds are found in higher concentrations in the air, feed, and food. Most PAHs are metabolized to hydroxylated compounds by the hepatic cytochrome P450 monooxigenases system. Metabolites are excreted into urine and feces. We determined concentrations of PH, PY and BaP in muscle and hydroxylated metabolites, 3-OH-PH, 1-OH-PY, and 3-OH-BaP, respectively, in urine from dairy cattle (n = 24). We also evaluated the relationship between parent compounds in muscle and their metabolites in urine. Concentrations of PH and PY in muscle ranged from 0.7~4.8 ng/g ($1.8{\pm}1.7$) and 0.4~4.1 ng/g ($1.2{\pm}1.2$), respectively. Concentrations of 3-OH-PH and 1-OH-PY in urine ranged from 0.1~5.9 ng/ml ($2.9{\pm}3.7$) and 0.5~3.6 ng/ml ($1.9{\pm}2.3$), respectively. Correlation coefficient for PY concentration in muscle versus 1-OH-PY in urine was 0.657 and for PH concentration in muscle versus 3-OH-PH in urine was 0.579. Coefficient determination for PY and PH concentrations in muscle was 0.886 and for 1-OH-PY and 3-OH-PH in urine was 0.834. This study suggests that 1-OH-PY and 3-OH-PH could be used as biomarkers for PAHs exposure in dairy cattle.